Opportunity

DIBBS #SPE2DP-26-T-2624

DLA Requests Ceftriaxone Injection from Approved Pharmaceutical OEMs for Fort Bragg Delivery

Posted

April 03, 2026

Respond By

April 08, 2026

Identifier

SPE2DP-26-T-2624

NAICS

325412

This procurement opportunity from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA seeks Ceftriaxone injection for delivery to a military facility. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - Approved OEMs: - HIKMA PHARMACEUTICALS USA INC. (part number NDC00143-9857-25) - SAGENT PHARMACEUTICALS, INC (part number NDC25021-0106-10) - WG CRITICAL CARE, LLC (part number NDC44567-0701-25) - Product Requested: - Ceftriaxone Injection, USP, 1 gram strength, NSN 6505-01-554-4282 - Each package contains 25 single-use vials - Total quantity: 7 packages - Must be sterile, labeled per Medical Marking Standard No. 1A - Minimum 21 months shelf life at receipt - Storage: 20 to 25°C, protected from light - Delivery & Performance: - Delivery required within 20 days of award - FOB destination to 3D SFG SSA AWCF SSF, Fort Bragg, NC - Compliance Requirements: - Must comply with Buy American Act - NIST SP 800-171 cybersecurity assessment required - No technical attachments provided - Solicitation is tagged for fast award

Description

CEFTRIAXONE INJECTI (QTY: 7, NSN: 6505-01-554-4282, Purchase Request: 7016172241) Approved Sources: - CAGE: 32655, Part No: NDC00143-9857-25, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 4RP13, Part No: NDC25021-0106-10, Company: SAGENT PHARMACEUTICALS, INC - CAGE: 6XJQ8, Part No: NDC44567-0701-25, Company: WG CRITICAL CARE, LLC

View original listing